NCT00665093View on ClinicalTrials.gov

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

1,569

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

biphasic insulin aspart 30

Start dose and frequency prescribed by the physician as a result of a normal clinical evaluation

DRUG

insulin detemir

Start dose and frequency prescribed by the physician as a result of a normal clinical evaluation

Trial Locations (1)

MK-1000

Novo Nordisk Investigational Site, Skopje

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY